Safety and Efficacy of AT-1501 in Patients With IgA Nephropathy (IgAN)
Clinical trial NCT05125068 · TERMINATED
Trial details
- NCT number
- NCT05125068
- Sponsor
- Eledon Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-21
- Primary completion
- 2023-07-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.